Resources

CDC creates interactive education module to improve RMSF recognition


 

The Centers for Disease Control and Prevention has created a first-of-its-kind interactive training module to help physicians both recognize and diagnose Rocky Mountain spotted fever (RMSF).

This image depicts the characteristic rash that had been caused by Rocky Mountain spotted fever. CDC

This image depicts the characteristic rash that had been caused by Rocky Mountain spotted fever.

A record number of cases of RMSF were reported to the CDC in 2017 (6,248, up from 4,269 in 2016), but less than 1% of those cases had sufficient laboratory evidence to be confirmed. The CDC education module includes scenarios based on real cases to aid providers in recognizing RMSF and differentiating it from similar diseases. CME is available for physicians, nurse practitioners, physician assistants, veterinarians, nurses, epidemiologists, public health professionals, educators, and health communicators.

The standard treatment for people of all ages with RMSF is doxycycline, preferably within the first 5 days of illness to prevent disability and death. The disease initially presents with nonspecific symptoms such as fever, headache, or rash, but if left untreated, patients may require the amputation of fingers, toes, or limbs because of low blood flow; heart and lung specialty care; and ICU management. About 20% of untreated cases are fatal; half of these deaths occur within 8 days of initial presentation.

“Rocky Mountain spotted fever can be deadly if not treated early – yet cases often go unrecognized because the signs and symptoms are similar to those of many other diseases. With tickborne diseases on the rise in the U.S., this training will better equip health care providers to identify, diagnose, and treat this potentially fatal disease,” said CDC director Robert R. Redfield, MD.

Find the full press release on the CDC website.

Recommended Reading

Zika virus vaccine trial launches
MDedge Internal Medicine
AHA: Chagas disease and its heart effects have come to the U.S.
MDedge Internal Medicine
Outpatient costs soar for Medicare patients with chronic hepatitis B
MDedge Internal Medicine
Experimental drugs deployed in Ebola response
MDedge Internal Medicine
Novel recombinant vaccine protects animals from Lassa fever
MDedge Internal Medicine
Deadly Marburg virus found in West Africa
MDedge Internal Medicine
2019 ID update for dermatologists: Ticks are the “ride of choice” for arthropods
MDedge Internal Medicine
Delaying antibiotics in elderly with UTI linked to higher sepsis, death rates
MDedge Internal Medicine
Fournier gangrene cases surge in patients using SGLT2 inhibitors
MDedge Internal Medicine
Is it measles? – Diagnosis and management for the pediatric provider
MDedge Internal Medicine